Sam Lee - Cocrystal Pharma Insider

Cocrystal Pharma Inc -- USA Stock  

USD 5.03  0.0009  0.0179%

Co-Founder and Pres

Dr. Sam Lee is the President of Cocrystal Pharma, Inc. Dr. Lee has served as President of Cocrystal since January 2, 2014. From January 2, 2014 until November 22, 2014, He was a director of Cocrystal. He is a cofounder of Cocrystal Discovery and was President and a director of Cocrystal Discovery since 2007. He has 17 years of antiinfective drug discovery research experience. Prior to being a cofounder of Cocrystal, he managed antiinfective, oncology, and inflammation drug discovery projects for eight years at ICOS Corporationrationration
Age: 55  Founder Since 2014  Ph.D    
Lee was responsible for incorporating protein crystallography and structural biology approaches into ICOS research. He received his Ph.D. in Biological Sciences from the University of Notre Dame, and completed postdoctoral training in viral replication biochemistry with Dr. I. R. Lehman at Stanford University. While at Stanford, Dr. Lee founded and was CEO of Viral Assays in Cupertino, CA.

Management Efficiency

The company has return on total asset (ROA) of (36.72) % which means that it has lost $36.72 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (53.44) % meaning that it created substantial loss on money invested by shareholders.

Entity Summary

Cocrystal Pharma, Inc., a clinical stage biotechnology company, focuses on the discovery and development of antiviral therapeutics for the treatment of serious andor chronic viral diseases. Cocrystal Pharma, Inc. was founded in 2007 and is headquartered in Tucker, Georgia. Cocrystal Pharma operates under Drug Related Products classification in USA and traded on OTC Market. It employs 18 people.Cocrystal Pharma Inc (COCP) is traded on OTC Market in USA. It is located in 1860 Montreal Road and employs 18 people.

Did you try this?

Run Volatility Analysis Now

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
Hide  View All  NextLaunch Volatility Analysis

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Cocrystal Pharma Inc to your portfolio

Top Management

Cocrystal Pharma Inc Leadership Team
Sam Lee, Founder, Ph.D
Raymond Schinazi, Director, CFA
Gary Wilcox, Chairman, Ph.D
James Martin, CFO
Jeffrey Meckler, CEO
Curtis Dale, CFO
Steven Rubin, Director
Phillip Frost, Director
David Block, Director
Douglas Mayers, Executive
Walt Linscott, Director
Jane Hsiao, Director, Ph.D

Stock Performance

Cocrystal Pharma Performance Indicators